22157.jpg
Global Chronic Kidney Disease Market Poised for Growth, Projected to Reach $83.6 Billion by 2030
January 23, 2024 03:08 ET | Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Chronic Kidney Disease Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering. ...
lexaria.jpg
Lexaria Bioscience Corp. (NASDAQ: LEXX) Proprietary Drug-Delivery System Improves Way Molecules Enter Bloodstream
January 11, 2024 08:30 ET | Lexaria Bioscience Corp.
NEW YORK, Jan. 11, 2024 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) announces the availability of a broadcast titled, “Exciting New Cures Possible from GLP-1...
ZyversaREV_cmyk.jpg
ZyVersa Therapeutics’ CEO, Stephen C. Glover, Featured on Benzinga All Access
January 10, 2024 08:06 ET | ZyVersa Therapeutics
View ZyVersa Therapeutics' Benzinga All Access Interview To Learn About Key Development Milestones in 2024.
ZyversaREV_cmyk.jpg
ZyVersa Therapeutics CEO, Stephen C. Glover, Issues Letter to Shareholders Providing Outlook for 2024
January 03, 2024 08:07 ET | ZyVersa Therapeutics
WESTON, Fla., Jan. 03, 2024 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA; “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for...
UNCY Logo.jpg
Unicycive Therapeutics Announces Enrollment of First Patient in Pivotal Clinical Trial for Oxylanthanum Carbonate (OLC) in Patients with Chronic Kidney Disease on Dialysis
December 18, 2023 07:03 ET | Unicycive Therapeutics, Inc.
LOS ALTOS, Calif., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the...
HealthMap_150x.90_1200.jpg
Healthmap Solutions Signs Health Equity Pledge
December 06, 2023 08:00 ET | Healthmap Solutions
Kidney population health management company Healthmap Solutions, Inc. signs Health Evolution Forum’s Health Equity Pledge.
American Kidney Fund
American Kidney Fund Hosts Fourth National Summit on Unknown Causes of Kidney Disease
December 05, 2023 08:34 ET | American Kidney Fund
ROCKVILLE, Md., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Today, the American Kidney Fund (AKF) will convene more than 100 medical leaders, patient advocates and academic and industry leaders for the fourth...
American Kidney Fund
American Kidney Fund Renews Calls for Early Diagnosis and Treatment of Chronic Kidney Disease in New Report
November 30, 2023 09:23 ET | American Kidney Fund
ROCKVILLE, Md., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Today the American Kidney Fund (AKF) released a new report that urges policymakers and advocates to broadly support measures—including improved...
UNCY Logo.jpg
Unicycive Therapeutics to Participate in Two Investor Conferences in December 2023
November 29, 2023 07:03 ET | Unicycive Therapeutics, Inc.
LOS ALTOS, Calif., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY) (the “Company” or “Unicycive”), a clinical-stage biotechnology company developing therapies for...
AHN Team
Africa Healthcare Network (AHN) Secures $20 Million in funding led by Africa50 and AfricInvest for a continent-wide expansion
November 22, 2023 06:30 ET | Africa Healthcare Network
Africa Healthcare Network (AHN), a leading provider of dialysis services in Africa, has secured $20 million in equity and debt funding.